School of Medicine


Showing 1-10 of 561 Results

  • Genevieve D'Souza

    Genevieve D'Souza

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    BioGenevieve D’souza MD, FASA is a Clinical Associate Professor in the Pediatric Anesthesia division of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University. She is a Board-certified Pediatric Anesthesiologist , Fellowship trained Pediatric Pain Doctor, and trained in Medical Acupuncture.
    She is a practicing Chronic Pediatric Pain Doctor at Stanford Medicine Children's Health and is also part of the Acute Pain Service. She is the Interim Medical Director of the Pediatric Pain Division. She is also the Director of the Pediatric Anesthesia Resource Center at Lucile Packard Children’s Hospital.
    She is also the Senior Editor for the Visual Pearl Series For the Society of Pediatric Pain Medicine and on the Board of Directors for Society of Pediatric Pain Medicine.

  • Peter D'Souza

    Peter D'Souza

    Clinical Associate Professor, Emergency Medicine

    BioDr. D'Souza's clinical practice is in Emergency Medicine at Stanford Hospital. He has a strong interest in Emergency Medical Services and pre-hospital care. He currently serves as medical advisor for the Palo Alto Fire Department, Mountain View Fire Department, and Santa Clara Fire Department. He serves as the Department Liaison to the Trauma Service. He previously served as Medical Director for Stanford Life Flight and course director for the Stanford EMT Training Program. His research interests include treatment of neurological emergencies and variability in trauma care.

  • Meysam Dadgar

    Meysam Dadgar

    Postdoctoral Scholar, Molecular Imaging Program at Stanford

    BioMeysam Dadgar is a Postdoctoral Research Fellow at the Molecular Imaging Program at Stanford, School of Medicine. He obtained his Ph.D. in Biophysics as part of the J-PET collaboration at Jagiellonian University in Kraków, Poland. His research focuses on the development and optimization of advanced PET imaging systems for early cancer detection, integrating state-of-the-art medical imaging technologies, signal processing, and AI-based image enhancement techniques to improve diagnostic accuracy and patient outcomes.

  • Saurabh Dahiya, MD, FACP

    Saurabh Dahiya, MD, FACP

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    BioDr. Dahiya is a cancer specialist with board certification in internal medicine, hematology, and medical oncology. He is an Associate Professor at Stanford University School of Medicine and Clinical Director of Cancer Cell Therapy in the Stanford BMT and Cell Therapy division.

    Dr. Dahiya strives to support each patient with a personalized and compassionate care plan that optimizes healing and quality of life.

    Prior to joining Stanford, Dr. Dahiya was an associate professor of medicine at the Greenebaum Comprehensive Cancer Center at the University of Maryland School of Medicine, where he developed the Cellular Immunotherapy Program and served as the Director of Cellular Immunotherapy in leukemia and lymphoma.

    Dr. Dahiya’s research focuses on cellular immunotherapy for hematologic malignancies. He has led and participated in several investigator-initiated studies and sponsored clinical trials with cell therapies (CAR-T, CAR-NK, TCR-T) for hematologic malignancies. His research group is also involved in various translational research activities for the standard of care and research CAR-T therapy. Dr. Dahiya’s group was the first group to show the role of fibrinogen in Neurotoxicity associated with CAR-T therapy. They showed vascular injury as manifested by high fibrinogen levels is associated with higher Neurotoxicity in patients who receive CAR-T therapy. More recently his group led a novel study of assessing the immune response to COVID-19 disease. They evaluated the immune response in critically ill and non-critically ill patients hospitalized with COVID-19 disease and showed a differential immune response between the groups. Dr. Dahiya’s group also showed and established poor immunogenicity of COVID-19 vaccines in CART recipients. As such, passive immunity and other strategies to address the issues of immunogenicity are being explored.

    He has published more than 50 articles in peer-reviewed journals including the New England Journal of Medicine, Journal of Clinical Oncology, Blood, Blood Advances, Lancet, Leukemia Research, Neuro-Oncology, and many more. He reviews article submissions for the journals Critical Reviews in Oncology and Hematology, Thoracic Cancer, and Blood. He serves as the hematology lead editor for the journal Critical Reviews in Oncology and Hematology.

    He has presented his research findings at conferences such as the annual meetings of the American Society of Hematology, American Society of Clinical Oncology, and American Society for Transplantation and Cell Therapy.

    Dr. Dahiya is a member of the American Society of Hematology and the American Society of Transplantation and Cell Therapy.